Creative Biolabs-Immuno-oncology

Anti-FASLG (clone 4G22D) SynExpress E1-BF-L/T-E CD8+ T Cells (CAT#: ITS-1124-CR461)

DatasheetDatasheet
Description
This product utilizes CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target FASLG ( clone 4G22D). We employs the HBV (EF1α-BFP-LEF/TCF-EcoRI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
FASLG
Clone
4G22D
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
BFP
Promoter
EF1α
Effector Gene
LEF/TCF
Insertion Sites
EcoRI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
HBV
Transformation Accuracy
0.87
Cell Culture
Aseptic Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.